Page 10 - HIV/AIDS Guidelines

Members Representing Department of Health and Human Services Agencies

Victoria Cargill National Institutes of Health, Rockville, MD
Laura Cheever Health Resources and Services Administration, Rockville, MD
Jonathan Kaplan Centers for Disease Control and Prevention, Atlanta, GA
Kendall Marcus Food and Drug Administration, Silver Spring, MD
Henry Masur National Institutes of Health, Bethesda, MD
Lynne Mofenson National Institutes of Health, Bethesda, MD
Kimberly Struble Food and Drug Administration, Silver Spring, MD

Non-Voting Observer
Monica Calderon National Institutes of Health, SAIC-Frederick, Inc., NCI-Frederick,
Frederick, MD

Acknowledgement

The Panel would like to acknowledge the assistance of Sarita D. Boyd, Pharm.D., (Food and Drug
Administration) for her assistance in updating the drug interaction tables and Satish Gopal, M.D., Ph.D.,
(University of North Carolina) and Ronald Mitsuyasu, M.D., (University of California–Los Angeles) for
their assistance with the “Malignancies” discussion in Initiating Antiretroviral Therapy.

Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents viii

Downloaded from http://aidsinfo.nih.gov/guidelines on 12/8/2012 EST.